Supernus Pharmaceuticals | Innovating CNS Treatments
Supernus, a biopharmaceutical company, develops CNS disease treatments. Transforming patient care with cutting-edge therapies and strategic partnerships.
U.S. FDA approves Supernus' drug-device combination for …
6 days ago · The drug-device combo, which Supernus acquired through a $530-million deal, opens new tab in 2020, continuously delivers the drug apomorphine under the skin, providing …
About Us - Supernus
At Supernus, we develop innovative products that help treat neurological and psychiatric conditions. It's about more than science and research, though. It's about the real impact these …
Supernus Announces FDA Approval of ONAPGO™ (apomorphine …
6 days ago · Supernus Pharmaceuticals, Inc. ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced …
Supernus CNS Products | Neurology & Psychiatry Conditions
At Supernus, we create innovative products to treat neurology and psychiatry conditions, focusing on their real impact in improving people's health.
FDA Approves Apomorphine Infusion Device SPN-830 as New …
Feb 4, 2025 · Nearly 4 and a half years since its original submission, the FDA has approved Supernus Pharmaceuticals’ investigational agent SPN-830 (Onapgo) as the first and only …
Supernus Pharmaceuticals Announces FDA Approval of ONAPGO, …
6 days ago · Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.
Supernus wins FDA approval for Parkinson’s pump on fourth try
4 days ago · Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory …
subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson s disease (PD). Supernus will make ONAPGO available in the second …
Supernus Announces FDA Approval of ONAPGO ... - Markets Insider
6 days ago · Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.